HongKong’sBiomedicalTechnologyEcosystem% · HKSTP Corporate Venture Funds is Raised Fund(I...

Hong  Kong’s  Biomedical  Technology  Ecosystem  

George  Tee Chief  Technology  Officer Hong  Kong  Science  and  Technology  Parks  Corpora<on  

January  2019

Hong  Kong  Science  Park:    Innova<on,  Technology,  Entrepreneurship

Hong  Kong  Science  Park:    Innova<on,  Technology,  Entrepreneurship

330,000  m2     R&D  Office  Space

Officially  opened  in    2002

700  Tech  Enterprises  

11,000  working  popula<on

Leading  Technology  Incubator  in  town  with  

240  

start-­‐ups  in  programmes

22  Na<onali<es  of   Park  Companies

Hong  Kong’s    I&T  hub  together  

with  InnoCentre  and  Industrial  Estates

Sha7n   Kowloon  Tong Taipo   Yuen  Long  

Tseung  Kwan  O

Science  Park  Research  &    Development  

Industrial    Estates  

Manufacturing  

InnoCentre  Design  &  Fintech  

*Updated  in  December  2018

Innova<on  as  the  Backbone  –  Key  Technology  Focus  

Healthcare  Technologies

Smart  Ci<es

FinTech

Ar<ficial  Intelligence  &  

Robo<cs

HKSTP’s  Technology  Clusters  Technology  Focus  Areas  

Biomedical  Technology

Material  &  Precision  

Engineering

Green   Technology

Informa<on  &  Communica<on  Technology  (ICT)

Electronics

HKSTP Key Achievements – 17 Years, and 2018

*Updated  in  September  2018

1st     Unicorn

Successfully  built  partnerships  with   60  corpora<ons:   Airport  Authority,  CLP,  Maxim’s,  Ocean  Park,  New  World,  HKT,  Hutchison,  HKJC,  MTR

Companies  expanded  into  China,  regional  and  globally,  with  HKSTP’s  support

Investment  Raised…FY17/18

Fund  raised  for  all   Park  companies $153  M  USD 6X Fund  raised  for  incubatees  and  graduates  in  

17/18  compared  to  16/17

577 Graduated  from  Incuba<on  Programmes  since  incep<on 440 S<ll  in  

Business 4 Completed  IPOs  

Incuba<on  –  Incu-­‐App,  Incu-­‐Tech,  Incu-­‐Bio…so  far

ITF

 Partner  Companies  

Universities

Private Equity / Venture Capital

Strategic Corporate Partners

Research Institutes

Government  &      Industry  Associa=ons  

Business  matching    

Sponsored  accelera=on  programs  

Funding  /  Investment  

Talent    Technologies  Transfer  

Sharing  Facili=es  

Standards,  advocacy  &  influence    in  regula=ons  and  adop=on  

HKSTP  –  a  plaHorm  for  Innova=on  &  Technology  Ecosystem

Biomedical Technology Cluster @HKSTP

Ø  110+  Partner  Companies  and  Incubatees  Ø  1,000+  researchers  from  12  countries  

Others  

Diagnos7cs  

Medical  Devices  

Pharmaceu7cs  

Stem  Cell  &  Regenera7ve  Medicine  

Tradi7onal  Chinese  Medicine  

Sub-­‐cluster  Distribu7on    (Partner  Companies)  

Partner Companies

and Incubatees

Diagnos7cs   Medical  Devices  

Pharmaceu7cs  

Tradi7onal  Chinese  Medicine   Stem  Cell  &  Regenera7ve  Medicine  

Others  

《2018/2019  Government  Budget》  Focus  on  Innova7on  &  Technology

Bio  Tech   A.I.  &  Robo7cs  

Smart  City   Fintech  

USD  6.4  Billion  

《2018/2019  Government  Budget》  Focus  on  Innova7on  &  Technology

First  phase  of  the  HK-­‐SZ  Innova7on  and  Technology  Park  in  the  Lok  Ma  Chau  Loop  

§  CyberPort  §  Technology  Talent  Scheme  

§  Postdoctoral  Hub  

§  Healthcare  Technologies  

 §  A.I.  &  Robo=cs  

•  Research-­‐related  Infrastructure  and  Facili<es

•  Strengthened  support  measures  for  Park  companies

§  Innova=on  and  Technology  Fund  (ITF)  

2.55B HK SZ

I&T Park

1.28B ITF

63.9M Talents

1.28B Science

Park

1.28B Two

Research Clusters

38.3M CyberPort

USD 6.4+ Billion

Bio  Tech   A.I.  &  Robo7cs  

Smart  City   Fintech  

Figures  in  USD  

 Future  Development  –  USD  1.28B  Funding  

   Item  

Es7mated  Cost  (USD$  million)  

1   Expansion  of  Incuba=on  Programmes   307  

2   Support  for  Tenants   383  

3   Accommoda=on  Support   12  

4   Expansion  of  CVF   64  

5   Smart  Campus     38  

6   Ancillary  Facili=es   69  

7   Provision  of  lab  spaces  for  healthcare  and  AI  and  robo=cs  technologies  researches  

59  

8   Facili=es  for  healthcare,  AI  and  robo=cs  technologies  researches

345  

    TOTAL: 1277  

Three  Focus  Areas:  

•  Strengthen  support  for  local  and  overseas  start-­‐ups  and  technology  companies  and  a`ract  them  to  join  the  ecosystem  

•  Provide  a  full  range  of  value-­‐added  services,  including  fund  raising  and  go-­‐to-­‐market  support,  etc.    

•  Enhance  and  set  up  exis=ng  and  new  research  and  development  facili=es  to  meet  market  and  industry  needs  

•  4-­‐year  program  •  All  rounded  support  •  USD  510K  +  255K  subsidy  Professional  

 Coaching    

Fund-­‐raising  &  Financial  support  

Shared  Equipment  &  Facili=es  

Talents  

Objec7ves      

•  Growth  :  Offering  1-­‐stop  biomedical  technology  focused  services  to  startups    

•  Commercializa7on:  Assis=ng  transla=on  of  research,  tapping  into  the  Asian/Chinese  market  

•  Financial    Sustainability  :  Providing  capital  (subsidy,  investment)  to  support  startups  through  the  “Valley  of  Death”  

Professional    Services    

Regulatory  Support  

Incu-Bio Program

BMT  Ecosystem  /  Industry  

Talent  Acquisi<on  Support

Max.  monthly  allowance:      ~USD  $2,400  

Max.  monthly  allowance:      ~USD  $4,000  

Bachelor  /  Master  degree  from  local  university    

Doctoral  degree  from  local  university  or  well-­‐recognised  non-­‐local  

ins7tu7on  

Internship Programme

Postdoctoral Hub

•  Postdoctoral  Hub  Programme  (PH-­‐SPC)  under  Technology  Talent  Scheme  (NEW)  

•  Internship  Programme  (IP-­‐SPC)    •  Technology  Talent  Admission  Scheme  

(TechTAS)  

HKSP  Incubatees  and  Partner  Companies  

Max.  2  interns  +  2  postdocs  at  any  

one  7me  (Max.  24  mnths)  

Deal Flows Transaction Support Over 600 Companies

Tenants Global Acceleration Academy

LEAP Universities

Research Institute Co-working Spaces

Multi-Channel Fundraising

HKSTP network HKBAN VIAHK

天使匯中國⻘青年天使會

Roadshow, Matching, Events, Community

Comprehensive Advisory

HKSTP Investment Team Professional Clinic

Lawyers, CPAs, IP Specialists Marketing Consultants etc.

Training, Coaching, Consulting

HKSTP Investment Service Platform

Investment Raised…FY17/18 USD 153m

USD 86.0m USD 6.4m is Committed by CVF

:

HKSTP Corporate Venture Funds

is Raised

Fund  I  

Fund  II   USD 25.0m Additional fund to invest into startups in HKSTP

A co-investment fund focusing on Seed to Series A investment in HKSTP companies

Biomedical Technology (BMT)

Information & Communication

Technology (ICT) Electronics

Material & Precision Engineering

Green Technology

1 13.4

Others   USD 40+m Other investment modes to support the ecosystem

Labs and Services Support Biomedical  Technology  Support  Centre  (BSC)  

•  Area:  8,900  sq.i.    •  Nature:  co-­‐working  space  •  23  offices  ranging  from  100-­‐150  sq.i.  •  20  floa=ng  desks  •  Product  prototype  tes=ng  room  (~800  sq.i.)  •  15  companies  moved  in  (70-­‐80%  occupancy  rate)    

Healthcare  Devices  Innova7on  Hub  (HDIH)  

•  Area:  8,700  sq.i.    •  Nature:  communal  lab  •  80+  pieces  of  ready-­‐to-­‐use  life  science  instruments  for  shared  

R&D  use  •  Culture  Room,  Freeze  Dryer  Room,  Mass  Spectrometry  Lab,  

Microscope  Room,  Genomics  Lab,  Proteomics  Lab,  Bioanalysis  Lab,  Microbiology  Lab  …  

Translational Research Facilities

GLP    Biosamples  repository    Support  biomarker  discovery  and  efficacy  analyses    

Secured  and  centralized  Data  plaHorm  for  R&D    Data  management,  analy=cs,  sharing          

GMP    Facility  for  drug  materials  (Biologics  &  Cell  processing)    Provide  GMP  drug  quality  assessment  for  every  stage  of  clinical  trials    Device  standard  cer=fica=on  facility      

Bench  Transla'onal  Research  Bedside  

Biobank   Biomedical  Informa7cs   Drug  Safety  Center   Pilot  Batch  /    

Device  Tes7ng  

GLP    Drug  Safety  Center  for  drug  efficacy    Provide  GLP  in  vitro  and  in  vivo  drug  safety  and  toxicology  assessment    

Medical  database  and  informa7on  exchange  

Globally  recognized  clinical  trial  centers    

Unique  pa7ent  profiles  and  pathologies  

Capitalize  These  Advantages  in  Biomedical  Technology  in  Hong  Kong

Pre-­‐revenue  IPO  for  Biotech  chapter  

•  Incubators    

Golden  Opportunity  for:    

•  Investors  

•  Industry  Partners  

•  Startups/Companies  

•  Ins'tutes  

•  Talents  

Thank you